Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

Recruiting Phase 1 Interventional Study
Healthy Male Volunteers
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 65
Sex
Male
Trial phase
Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
10 (estimated)
Sponsor
Grünenthal GmbH · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Healthy volunteers 2. Aged 30 to 65 years inclusive at the time of signing informed consent Exclusion Criteria: 1. Serious adverse reaction or serious hypersensitivity to any drug or formulation excipients 2. Presence or history of clinically significant allergy requiring t…
Contacts

Grünenthal Clinical Trial Information

+49 241 569 3223

clinical-trials@grunenthal.com

CONTACT

Transparency and Public Disclosure Coordinator

clinical-trials@grunenthal.com

CONTACT